• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Cambridge Heart shifts gears on MTWA test

Cambridge Heart shifts gears on MTWA test

June 23, 2009 By MassDevice staff

Cambridge Heart Inc. said it plans to shift gears and market an OEM version of its Microvolt T Wave Alternans test to other manufacturers, to boost slumping sales of a product it says can determine the risk of a sudden heart attack.

The Tewksbury-based cardiac monitor maker said the company’s new marketing model involves offering the MTWA sensor technology for incorporation into other company’s stress-test products. Cambridge Heart said it’s already found its first partner, inking a non-exclusive development and distribution agreement with a “leading U.S. stress manufacturer.”

Citing “competitive considerations,” the company declined to name the partner until its product was ready for launch, in nine to 15 months.

Cambridge Heart, which likens the MTWA test to a simple treadmill-based stress test, has been dogged by reimbursement woes. It’s had difficulty getting the test covered by some of the largest private health insurers in the world, including United Health and several Blue Cross/Blue Shield affiliates, and lost a coverage decision at Well Point.

The company estimates that 20 percent of patients who could benefit from the product do not have access to it due to reimbursement issues.

The latest move isn’t completely unexpected; Cambridge Heart telegraphed its punch last month when it cut roughly 30 percent of its internal sales force to lower costs in the face of a growing capital equipment slump. Officials said then that the company would shift to using more outside distributors.

During the first quarter of 2009, Cambridge Heart posted $836,000 in sales, a 29 percent decrease from the $1.1 million it reported during the same period last year. Despite the slide, it managed to narrow its losses through a series of cost-cutting initiatives to $2.2 million, compared to $2.4 million for the 2008 first quarter.

Filed Under: Business/Financial News, Diagnostics

More recent news

  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment
  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit
  • Medtronic issues safety notice for Hugo surgical robot console in Europe
  • Aortyx raises $16M for bioresorbable aortic patch

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy